Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SXTC
DateTimeSourceHeadlineSymbolCompany
05/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SXTCChina SXT Pharmaceuticals Inc
25/10/202416:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
22/10/202420:51Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SXTCChina SXT Pharmaceuticals Inc
15/10/202420:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
07/10/202420:15GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
13/08/202420:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
31/07/202420:15Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:SXTCChina SXT Pharmaceuticals Inc
14/05/202420:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
11/01/202421:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SXTCChina SXT Pharmaceuticals Inc
26/10/202320:05GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
04/10/202312:30GlobeNewswire Inc.China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
31/07/202320:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
19/05/202321:17Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/05/202312:00GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
29/03/202318:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
29/03/202317:50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
27/03/202310:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
28/02/202321:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
24/02/202322:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
13/02/202321:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
23/12/202211:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
07/11/202213:00GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
12/10/202212:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
27/09/202212:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
18/07/202215:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
18/05/202216:30GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
13/05/202220:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
11/05/202220:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
24/03/202220:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
16/03/202220:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SXTC